Tech Company Financing Transactions
NanoViricides Funding Round
NanoViricides closed a $5 million funding round on 6/29/2012. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/29/2012
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This new investment enables the Company to retain more than 24 months of current operating expenses as cash in hand. This strengthened financial position will allow the Company to defray certain additional testing costs for its anti-influenza drug candidate leading to an IND application, and to support the budgeted costs of certain additional equipment needed for production of the future clinical batches of its drug candidates.
Company Information
Company Status
Publicly-held
Industry
Nanotechnology
Mailing Address
1 Controls Dr.
Shelton, CT 06484
USA
Shelton, CT 06484
USA
Phone
Website
Email Address
Overview
NanoViricides (OTC BB: NNVC.OB) has assembled a world class team to lead us to success. We have brought together highly experienced individuals with strong expertise in their respective areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anil Diwan
Chief Financial Officer
Meeta Vyas
Chief Scientific Officer
Randall Barton
Browse more venture capital transactions:
Prev: 6/29/2012: SocialToaster venture capital transaction
Next: 6/29/2012: BillMyParents venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs